Travere Therapeutics Inc (TVTX) support and resistance · rev $233.2M
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
This page maps Travere Therapeutics Inc (TVTX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
TVTX currently screens at market cap $1.33B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new TVTX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the TVTX quote page for the session range and the stock page for the full model.
Not investment advice.